GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who lose only moderate amounts of weight at best, according to ...

Drugs like Wegovy and Zepbound are highly effective for weight loss. But researchers at the Society for Neuroscience meeting say they are only beginning to understand the drugs' effects on the brain.

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...

Explore Zepbound's "Changing the Threads" exhibit, which is redefining the stigma of obesity through powerful stories and ...

Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...

The shift shows up clearly in market valuations. At the end of March 2024, Novo Nordisk was worth over $500 billion and Lilly ...

Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. In European ...

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the ...

Good news for consumers battling the high cost of weight loss drugs. Novo Nordisk, the maker of Wegovy and Ozempic, announced ...